HealthMore in Health→
Why Africa’s Absence From Clinical Trials Matters Far Beyond Research Design
Key Takeaways
- The candidate argues that Africa is missing from too much of the clinical trial system.
- That underrepresentation is notable because the continent carries a large disease burden.
- The gap challenges the idea that modern medical evidence is fully universal.
- The issue has implications for both research quality and health equity.
DE
DT Editorial Team··via medicalxpress.com